-
Abbott Labs (ABT) PT Raised at RBC Capital Following Recent Stock Performance
-
Abbott Labs (ABT) PT Raised to $145 at RBC Capital, Citing 'Positive Business Fundamentals'
-
RBC Capital Assesses U.S. Tariff Impact Across Industries
-
RBC Capital: 'Opportunities Across MedTech Stocks'
-
RBC's Best Picks For 2025 in Medical Supplies & Devices: 'Oasis of Opportunity Awaits as MedTech Momentum Continues'
-
Abbott bumps up profit forecast on strong medical device sales
-
Abbott Labs (ABT) PT Lowered to $125 at RBC Capital
-
Abbott's device sales drive profit beat, but shares fall as forecast disappoints
-
RBC Capital Starts Abbott Labs (ABT) at Outperform
-
Abbott Labs (ABT) PT Raised to $92 at RBC Capital
-
Abbott Labs (ABT) PT Raised to $77 at RBC Capital
-
Abbott Labs (ABT) PT Raised to $70 at RBC Capital
-
Pre-Open Movers 01/02: (NETE) (WATT) (AKAO) Higher; (WFT) (TSRO) (MLCO) Lower (more...)
-
Notable Analyst Rating Changes 2/5: (GS) (ALL) (ABT) Upgraded; (LNKD) (KSS) (LINE) Downgraded
-
Notable Mergers and Acquisitions 2/1: (ABT)/(ALR) (D)/(STR) (MDT) (SYK) (AYA)
-
Notable Analyst Rating Changes 10/7: (CTRP) (MS) (ABT) Upgraded; (TSLA) (PSX) (BIDU) Downgraded
-
Drugmaker Abbott says not pursuing an offer for St Jude Medical
-
Notable Analyst Rating Changes 1/13: (AAPL) (ETFC) (BBY) Upgraded; (ABT) (GHL) (HPQ) Downgraded
-
Notable Analyst Rating Changes 10/29: (AMGN) (ALR) (ABT) Upgraded; (PBR) (KORS) (DTE) Downgraded
-
Notable Analyst Rating Changes 02/15: (NOK) (ATML) (XL) Upgradaed; (GOLD) (RIG) (LOGM) Downgraded
-
Notable Analyst Rating Changes 04/07: (HERO) (ELN) (CRM) Upgraded; (MDRX) (CNL) (SSW) Downgraded
-
RBC Upgrades Baxter (BAX) to Top Pick, Downgrades Abbott (ABT) to Outperform
-
Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta
-
RBC Raises Estimates on Abbott (ABT), Lowers Estimates on Boston Scientific (BSX)
-
David Moenning's Daily State of the Markets: 4/24
-
David Moenning's Daily State of the Markets: 4/6
-
RBC Capital Initiates Coverage on Several Medical Instruments & Supplies/Drug Stocks - Abbott Labs Named Top Pick

